Alex Chen has a diverse background in engineering and project management, with experience in various industries such as mining, biosciences, and transportation. Currently serving as the Managing Partner at Pangen Fund and President at uBriGene Biosciences International Co, Alex previously held positions such as Managing Director at Eastern Capital and Project Engineer at Rio Tinto. With a Master's degree in Project Management from The University of British Columbia, Alex has expertise in structural engineering, industrial building design, project delivery, and asset management.
This person is not in any teams
uBriGene Biosciences International Co.
3 followers
uBriGene Biosciences is a global leader for ATMPs PD, AD and GMP production. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT and mRNA product development. The uBriGene team of experts has strong expertise in advanced therapy development. The company's manufacturing and analytical platforms are designed to reduce costs, shorten lead times, and boost product yields for our global customers.